title: Treatment of severe MRSA infections: current practice and further development.
authors.affiliation: Department of Emergency and Intensive Care, Faculty of Medicine, Grupo de Infecçao e Sepsis, Centro Hospitalar Sao Joao, University of Porto, Porto, Portugal. jarturpaiva@gmail.com.
authors.forename: José-Artur
authors.initials: JA
authors.lastname: Paiva
authors.affiliation: Department of Emergency and Intensive Care, Faculty of Biology and Medicine, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
authors.forename: Philippe
authors.initials: P
authors.lastname: Eggimann
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D016638:Critical Illness / Q000401:mortality / Q000628:therapy; D017576:Daptomycin / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000401:mortality; D014640:Vancomycin / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D017576:Daptomycin